Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

 China Bio-Med (HKG:8158) FY12 NL widens to $57M; no div
CreateTime:2012-07-20     Source:chinesestock.org Editor:qulina
Text Size:       

Results of China Bio-Med Regeneration Technology Limited (HKG:8158) for the fiscal year ended 30 April 2012_:

Net loss: HK$57.109M (HK$42.061M net loss for previous same-period)
LPS: HK 0.809 cent
Interim dividend: nil


Related Reports
China Animal Vaccine Industry Report, 2019-2025
China Blood Product Industry Report, 2020-2026
China Vacuum Blood Collection Device Industry Report, 2019-2025
China Human Vaccine Industry Report, 2019-2025
China Independent Clinical Laboratory Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1